D. Jayaweera

D. Stablein, L. Ferrell, K. Olthoff, 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96

A. Pozniak, P. Yeni, B. Grinsztejn, 2009, Antiviral therapy.

Intravenous Mesenchymal Stem Cells in Extracorporeal Oxygenation Patients with Severe COVID-19 Acute Respiratory Distress Syndrome

H. Gershengorn, M. Loebe, A. Atala, 2020, medRxiv.

A Randomized Trial to Evaluate Lopinavir/Ritonavir versus Saquinavir/Ritonavir in HIV-1-Infected Patients: The Maxcmin2 Trial

B. Gazzard, Z. Fox, M. Youle, 2005, Antiviral therapy.

The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial*

J. Javitt, P. Lavin, D. Jayaweera, 2022, Critical care medicine.

Efficacy and safety outcomes among treatment-experienced women and men treated with etravirine in gender, race and clinical experience.

J. Mrus, D. Jayaweera, S. Hodder, 2012, AIDS research and human retroviruses.

F/C AETC Faculty HIV/HCV

D. Jayaweera, Maribel González, 2014 .

Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study

B. Chen, T. Hummel, A. Eshraghi, 2020, medRxiv.

Liver transplantation for HIV-infected patients with end-stage liver disease

A. Tzakis, D. Jayaweera, G. Neff, 2002 .

Virologic Suppression, Treatment Adherence, and Improved Quality of Life on a Once-Daily Efavirenz-Based Regimen in Treatment-Naïve HIV-1–Infected Patients Over 96 Weeks

E. Dejesus, D. Jayaweera, D. Butcher, 2009, HIV clinical trials.

Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression

M. Witt, D. Jayaweera, J. Maa, 2008, HIV clinical trials.

Outcomes After Orthotopic Liver Transplantation in 15 HIV-Infected Patients

E. Schiff, J. Gaynor, A. Tzakis, 2007, Transplantation.

Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial.

C. Farthing, D. Cooper, S. Walmsley, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug-Induced Liver Injury in HIV Patients.

K. Sherman, D. Jayaweera, G. Neff, 2006, Gastroenterology & hepatology.

Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease

E. Schiff, J. Fung, A. Tzakis, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Fulminant neuropathy and lactic acidosis associated with nucleoside analog therapy

R. Schein, D. Kett, D. Jayaweera, 1999, Neurology.

Minimising the Dosage-Limiting Toxicities of Foscarnet Induction Therapy

D. Jayaweera, 1997, Drug safety.

Efficacy, Safety and Pharmacokinetics of Once-Daily Saquinavir Soft-Gelatin Capsule/Ritonavir in Antiretroviral-Naive, HIV-Infected Patients

M. Saag, S. Walmsley, D. Jayaweera, 2006, MedGenMed : Medscape general medicine.

Short-term combined exercise training improves the health of HIV-infected patients

J. Lewis, Lawrence Chen, E. Tiozzo, 2013 .

Rejuvenation of Senescent Endothelial Progenitor Cells by Extracellular Vesicles Derived From Mesenchymal Stromal Cells

Qianhuan Zhang, J. Hare, Huilan Wang, 2020, JACC. Basic to translational science.

Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS

C. Farthing, B. Luft, J. Holden-Wiltse, 2001, AIDS.

Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine

K. K. Lai, D. Katzenstein, M. Hirsch, 1995 .

COVID19: A Systematic Approach to Early Identification and Healthcare Worker Protection

C. del Rio, F. Telischi, S. Daunert, 2020, Frontiers in Public Health.

Abuse and Mental Health Concerns Among HIV‐Infected Haitian Women Living in the United States

O. Villar-Loubet, D. Jayaweera, M. Kolber, 2014, The Journal of the Association of Nurses in AIDS Care : JANAC.

Zika Virus: An Emerging Global Health Threat

Amit P. Patel, X. Liu, R. Mittal, 2017, Front. Cell. Infect. Microbiol..

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients

Henry E. Wang, L. Pirofski, R. Sacco, 2021, JAMA internal medicine.

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.

A. Ginde, G. Felker, C. Lindsell, 2022, JAMA.

Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients.

D. Jayaweera, Allan E. Rodriguez, M. Kolber, 2005, AIDS.

Genotypic analysis of plasma HIV-1 RNA after influenza vaccination of patients with previously undetectable viral loads

D. Jayaweera, G. Dickinson, M. Kolber, 2002, AIDS.

MicroRNA-146a Induces Lineage-Negative Bone Marrow Cell Apoptosis and Senescence by Targeting Polo-Like Kinase 2 Expression

D. Dykxhoorn, Huilan Wang, Chunming Dong, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol

D. Dykxhoorn, Guerline Lambert, J. Hare, 2021, Frontiers in Cardiovascular Medicine.

Predicting COVID-19 cases using SARS-CoV-2 RNA in air, surface swab and wastewater samples

H. Solo-Gabriele, G. Grills, Sion L. Williams, 2022, Science of The Total Environment.

Gender Differences in Medication Management Capacity in HIV Infection: The Role of Health Literacy and Numeracy

R. Ownby, D. Waldrop-Valverde, Javier Romero, 2009, AIDS and Behavior.

Demographic representation in clinical trials for cell-based therapy

J. Hare, R. Mitrani, D. Jayaweera, 2021, Contemporary clinical trials communications.

Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study

T. Hummel, A. Eshraghi, Hongzhou Lu, 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.

A. Ginde, G. Felker, C. Lindsell, 2023, JAMA.

Prevention of Liver Fibrosis and Steatosis Progression Among Heavy Drinkers With and Without HIV After 30-Day Drinking-Reduction Program

R. Cook, D. Jayaweera, Zhigang Li, 2023, medRxiv.

When "access to antiretroviral treatment for all" is not enough

J. Page, D. Jayaweera, A. Campa, 2007 .

Optimizing Identification of People Living with HIV from Electronic Medical Records: Computable Phenotype Development and Validation

R. Cook, J. Bian, E. Shenkman, 2021, Methods of Information in Medicine.

The safety and efficacy of indinavir and ritonavir (400/400 mg BID) in HIV-1-infected individuals from an inner-city minority population: a pilot study

D. Jayaweera, M. Kolber, T. Tanner, 2003, International journal of STD & AIDS.

Disparities in HIV-treatment Responses between Haitians, African Americans, and Hispanics Living in Miami-Dade County, Florida

D. Jayaweera, K. Deeb, Linda N Nguyen, 2012, Journal of health care for the poor and underserved.

Prioritizing studies of COVID-19 and lessons learned

Denise H. Daudelin, A. Cameron, Alyssa B. Cabrera, 2021, Journal of Clinical and Translational Science.

Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients

C. Cohen, M. de Béthune, D. Berger, 2009, AIDS.

Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistance.

P. Lichtenberger, D. Jayaweera, Allan E. Rodriguez, 2003, AIDS research and human retroviruses.

Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.

Nicole M. Zaleski, Jana K. Shirey-Rice, Edward R. Armas, 2023, JAMA.

Blood Pressure and Marijuana Use: Results from a Decade of NHANES Data.

Sabita Roy, S. Messiah, D. Jayaweera, 2019, American Journal of Health Behavior.

Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).

M. Fletcher, N. Klimas, R. Patarca, 2003, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

Etravirine: the renaissance of non-nucleoside reverse transcriptase inhibitors

D. Jayaweera, L. Espinoza, J. Castro, 2008 .

Heart Health and Behavior Change in HIV-Infected Individuals

Mahendra Kumar, D. Jayaweera, D. Jones, 2020, AIDS and Behavior.

COVID-19 Prediction using Genomic Footprint of SARS-CoV-2 in Air, Surface Swab and Wastewater Samples

T. Babler, H. Solo-Gabriele, G. Grills, 2022, medRxiv.

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.

B. Luft, P. Morlat, C. Leport, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Wernicke's encephalopathy in AIDS: a preventable cause of fatal neurological deficit

M. Alcaide, D. Jayaweera, M. Kolber, 2003, International journal of STD & AIDS.

MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.

D. Stablein, P. Stock, J. Fung, 2010, Gastroenterology.